If the company’s C1, C2, C3 and T1 ventilators are used for more than 91 days without restarting, they pose a risk of switching to an “Ambient State.” The FDA classified the recall as Class I, the most serious type, because the problem could result in serious injury or death.
As of Aug. 30, Hamilton has reported 80 complaints and zero injuries or deaths related to the recall.
Healthcare professionals are instructed to provide alternative ventilation immediately.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
